Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro L Moro

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Obstetrics and Gynecology|February 21, 2014
In replyPedro L Moro
The Lancet. Infectious Diseases|February 6, 2017
Cholera vaccination: pregnant women excluded no morePedro L Moro, Lakshmi Sukumaran
Vaccine|December 28, 2020
Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020Pedro L Moro, Paige Marquez
Expert Review of Vaccines|December 27, 2021
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccinesPedro L Moro, Michael M McNeil
Vaccine|January 15, 2022
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Pedro L Moro
Vaccine|March 8, 2021
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting systemEmily Jane Woo, Pedro L Moro
Travel Medicine and Infectious Disease|June 18, 2019
Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006-2016Pedro L Moro, Paige Lewis, Maria Cano
Expert Review of Vaccines|October 4, 2019
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and PreventionPedro L Moro, Penina Haber, Michael M McNeil
American Journal of Obstetrics and Gynecology|March 5, 2013
Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting SystemYenlik Zheteyeva, Pedro L Moro, Xin Yue, et al.
The Journal of Pediatrics|July 30, 2023
Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting SystemPedro L Moro, Bicheng Zhang, Paige Marquez, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Obstetrics and Gynecology|February 21, 2014
In replyPedro L Moro
The Lancet. Infectious Diseases|February 6, 2017
Cholera vaccination: pregnant women excluded no morePedro L Moro, Lakshmi Sukumaran
Vaccine|December 28, 2020
Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020Pedro L Moro, Paige Marquez
Expert Review of Vaccines|December 27, 2021
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccinesPedro L Moro, Michael M McNeil
Vaccine|January 15, 2022
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting SystemEmily Jane Woo, Pedro L Moro
Vaccine|March 8, 2021
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting systemEmily Jane Woo, Pedro L Moro
Travel Medicine and Infectious Disease|June 18, 2019
Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006-2016Pedro L Moro, Paige Lewis, Maria Cano
Expert Review of Vaccines|October 4, 2019
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and PreventionPedro L Moro, Penina Haber, Michael M McNeil
American Journal of Obstetrics and Gynecology|March 5, 2013
Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting SystemYenlik Zheteyeva, Pedro L Moro, Xin Yue, et al.
The Journal of Pediatrics|July 30, 2023
Postmarketing Safety Surveillance of a Hexavalent Vaccine in the Vaccine Adverse Event Reporting SystemPedro L Moro, Bicheng Zhang, Paige Marquez, et al.
Pageof 11